Anaveo, a French provider of electronic security solutions to small and medium sized businesses, has been acquired by Bridgepoint Development Capital from its majority shareholder (M. Paul Surand) and minority financial investors (CM CIC, Garibaldi Participations and Viveris), for an undisclosed sum. Bpifrance and Paluel Marmont Capital partnered with BDC in the equity financing of the transaction.
Element Materials Technology, the global leader in materials and product qualification testing in the aerospace, oil & gas and transportation markets, has been acquired by Bridgepoint from 3i Group for an undisclosed sum.
LGC, the international life sciences company creating measurement and testing solutions for companies across the world, is to be sold by Bridgepoint for an undisclosed sum to KKR.
Quotient Clinical (‘Quotient’ or ‘the Company’), a provider of outsourced, early-stage drug development services to the global pharmaceutical industry, has been sold by Bridgepoint Development Capital (‘BDC’) to GHO Capital for an undisclosed sum. The sale has generated a strong money multiple for BDC and is its 3rd realisation this year.
Balt, the specialist manufacturer of 'Interventional Neuro Radiology’ (‘INR’) devices used to treat strokes and aneurysms, has been acquired by Bridgepoint for an undisclosed sum. Bridgepoint will work in partnership with Balt’s family founders to help the company accelerate its growth and capture market share within the expanding market for neurovascular devices.